Novocure Ltd (NVCR) is lower by Thursday morning, with the stock falling -1.09% in pre-market trading to 14.48. NVCR's short-term technical score of 13 indicates that the stock has traded less bullishly over the last month than 87% of stocks on the market. In the Medical Devices industry, which ranks 118 out of 146 industries, Novocure Ltd ranks higher than 23% of stocks. Novocure Ltd has fallen 1.74% over the past month, closing at $15.31 on February 29. During this period of time, the stock fell as low as $13.07 and as high as $18.04. NVCR has an average analyst recommendation of Buy. The company has an average price target of $25.29.
NVCR has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on NVCR!